Study on the polymorphisme of human leucocyte antigen--DRB1,-DQA1 and -DQB1 alleles in patients with hepatitis B
Iang Ye-gu
Abstract
Iang Ye-gu
Abstract
Objective To investigate the association between the polymorphism of human leucocyte antigen(HLA)-DRB1,-DQA1 and -DQB1 alleles and viral hepatitis B. Methods HLA-DRB1,-DQA1 and -DQB1 alleles in 52 patients with chronic hepatitis B, 30 patients with acute hepatitis B and 106 normal control subjects were analysed, using the polymerase chain reaction/sequence specific primer (PCR/ SSP) technique. Results The allele frequencies of HLA-DRB1 * 0301, -DQA1 * 0501 and -DQB1 * 0301 in the chronic hepatitis B group (17.31%, 25.96%, 35.58%) were markedly higher than that in the normal control group (5.67%, 13.36%, 18.87%), with statistical significance (X_1~2=12.3068, P_(c1)= 0.0074; X_2~2=9.2002, P_(c2)=0.0157; X_3~2x=15.5938, P_(c3)=0.0075). The allele frequencies of HLA-DRB1 * 1101/1104 and -DQA1 * 0301 in the chronic hepatitis B group (0.96%,14.42%) were markedly lower than that in the acute hepatitis B group (13.33%,30%), with significant correlation between them (X_1~2= 11. 9206,P_(c1)=0.0145;X_2~2=8.7396, P_(c2)=0.0167). Conclusion HLA-DRB1 * 0301,-DQA1 * 0501 and -DQB1 * 0301 were closely associated with the susceptibility to chronic hepatitis B, while HLA-DRB1 * 1101/1104 and -DQA1 * 0301 closely associated with the resistance to chronic hepatitis B. These findings suggested that host HLA class Ⅱ gene was an important factor determining the outcome of HBV infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the association between the polymorphism of human leucocyte antigen(HLA)-DRB1,-DQA1 and -DQB1 alleles and viral hepatitis B. Methods HLA-DRB1,-DQA1 and -DQB1 alleles in 52 patients with chronic hepatitis B, 30 patients with acute hepatitis B and 106 normal control subjects were analysed, using the polymerase chain reaction/sequence specific primer (PCR/ SSP) technique. Results The allele frequencies of HLA-DRB1 * 0301, -DQA1 * 0501 and -DQB1 * 0301 in the chronic hepatitis B group (17.31%, 25.96%, 35.58%) were markedly higher than that in the normal control group (5.67%, 13.36%, 18.87%), with statistical significance (X_1~2=12.3068, P_(c1)= 0.0074; X_2~2=9.2002, P_(c2)=0.0157; X_3~2x=15.5938, P_(c3)=0.0075). The allele frequencies of HLA-DRB1 * 1101/1104 and -DQA1 * 0301 in the chronic hepatitis B group (0.96%,14.42%) were markedly lower than that in the acute hepatitis B group (13.33%,30%), with significant correlation between them (X_1~2= 11. 9206,P_(c1)=0.0145;X_2~2=8.7396, P_(c2)=0.0167). Conclusion HLA-DRB1 * 0301,-DQA1 * 0501 and -DQB1 * 0301 were closely associated with the susceptibility to chronic hepatitis B, while HLA-DRB1 * 1101/1104 and -DQA1 * 0301 closely associated with the resistance to chronic hepatitis B. These findings suggested that host HLA class Ⅱ gene was an important factor determining the outcome of HBV infection.
Key concepts: Allele, Human leukocyte antigen, Immunology, Medicine, Hepatitis, Hepatitis B, HLA-DRB1, Antigen